Kinbank: A global database of kinship terminology

For a single species, human kinship organization is both remarkably diverse and strikingly organized. Kinship terminology is the structured vocabulary used to classify, refer to, and address relatives and family. Diversity in kinship terminology has been analyzed by anthropologists for over 150 years, although recurrent patterning across cultures remains incompletely explained. Despite the wealth of kinship data in the anthropological record, comparative studies of kinship terminology are hindered by data accessibility. Here we present Kinbank, a new database of 210,903 kinterms from a global sample of 1,229 spoken languages. Using open-access and transparent data provenance, Kinbank offers an extensible resource for kinship terminology, enabling researchers to explore the rich diversity of human family organization and to test longstanding hypotheses about the origins and drivers of recurrent patterns. We illustrate our contribution with two examples. We demonstrate strong gender bias in the phonological structure of parent terms across 1,022 languages, and we show that there is no evidence for a coevolutionary relationship between cross-cousin marriage and bifurcate-merging terminology in Bantu languages. Analysing kinship data is notoriously challenging; Kinbank aims to eliminate data accessibility issues from that challenge and provide a platform to build an interdisciplinary understanding of kinship.

Continuous wave interdigital H-mode cavities for alternating phase focusing heavy ion acceleration

In the future, a new superconducting (SC) continuous wave (CW) high intensity heavy ion HElmholtz LInear ACcelerator (HELIAC) should provide ion beams with maximum beam energy above the Coulomb barrier for the Super Heavy Element program at GSI (Gesellschaft für Schwerionenforschung, in Engl.: Association for Heavy Ion Research). The HELIAC consists of a SC main accelerator supplied by a normal conducting injector, which comprises an electron cyclotron resonance ion source, a radio-frequency quadrupole, and two separate interdigital H-mode drift-tube linear accelerator cavities, based on an Alternating Phase Focusing (APF) scheme. Together, both cavities will accelerate ions from 300 to 1400 keV/u with only one external quadrupole triplet for transverse focusing in between. Due to the demanding requirements of the APF concept on the voltage distribution along the beam axis on the one hand and the CW operation on the other hand, the optimization of each cavity concerning RF, mechanical, and thermal properties is crucial for the successful operation of the HELIAC injector.

A dynamic collimation and alignment system for the Helmholtz linear accelerator

The upcoming commissioning of the superconducting (SC) continuous wave Helmholtz linear accelerators first of series cryomodule is going to demand precise alignment of the four internal SC cavities and two SC solenoids. For optimal results, a beam-based alignment method is used to reduce the misalignment of the whole cryomodule, as well as its individual components. A symmetric beam of low transverse emittance is required for this method, which is to be formed by a collimation system. It consists of two separate plates with milled slits, aligned in the horizontal and vertical direction. The collimation system and alignment measurements are proposed, investigated, and realized. The complete setup of this system and its integration into the existing environment at the GSI High Charge State Injector are presented, as well as the results of the recent reference measurements.

Production of high current proton beams using complex H-rich molecules at GSI

In this contribution, the concept of production of intense proton beams using molecular heavy ion beams from an ion source is described, as well as the indisputable advantages of this technique for operation of the GSI linear accelerator. The results of experimental investigations, including mass-spectra analysis and beam emittance measurements, with different ion beams (CH3(+),C2H4(+),C3H7(+)) using various gaseous and liquid substances (methane, ethane, propane, isobutane, and iodoethane) at the ion source are summarized. Further steps to improve the ion source and injector performance with molecular beams are depicted.

Abstract 2525: Intravenous infusions of TriN 2755, a new alkylating agent, inhibit the growth of human MDA-MB-231 breast tumor in nude rats

Background: The new cytotoxic anti-neoplastic agent TriN 2755, containing a triazene unit with alkylating properties, exhibited a potent antitumor activity in a large panel of human xenograft tumor models in mice when dosed by IV bolus injection. In rat, dog and mini pig toxicity studies, TriN 2755 demonstrated a favourable safety profile. Here, we present efficacy data of TriN 2755 intravenously injected in the MDA-MB-231 tumor bearing Nude rat model.

Material and methods: The breast tumors were induced subcutaneously by injecting 2×107 of MDA-MB-231 cells in 200 µl of RPMI 1640 containing matrigel (50:50, v:v). Tumor-bearing nude rats received a single 4-hour IV infusion of TriN 2755 at 30, 80 or 240 mg/kg/infusion or IV bolus injection of TriN 2755 at 160, 240 or 360 mg/kg/injection twice weekly for 4 consecutive weeks. Moreover, two groups of rats received a single 4-hour IV infusion of TriN 2755 at 240 mg/kg/infusion twice weekly for 4 consecutive weeks in combination with repeated weekly IV bolus injection of CPT-11 at 40 mg/kg/inj for 4 consecutive weeks or Docetaxel at 2.5 mg/kg/inj for 3 consecutive weeks. The treatment started when the mean tumor volumes reached about 400-800 mm3, and the antitumor activity of TriN 2755 was assessed as tumor volume inhibition relative to a vehicle control group (T/C value in %). Tolerability was analysed by recording mortality and body weight loss.

Results: Repeated IV infusions of TriN 2755 were well tolerated by female nude rats bearing subcutaneous (SC) MDA-MB-231 tumors at all tested doses (no death, no body weight loss).

The histopathological analysis of liver, kidneys, and bone marrow of treated rats revealed no treatment related changes. Based upon TriN 2755 antitumor efficacy criteria at 80 and 240 mg/kg when injected by IV infusion, and at 160, 240 or 360 mg/kg when injected by IV bolus displayed a marked, and dose-dependent antitumor activity against SC MDA-MB-231 tumor (Optimal T/C% values were 37, and 7%, 21, 19 and 12%, respectively) Tumor regressions were observed after two weeks of treatment for all rats treated with TriN 2755 administered by IV bolus or IV infusion of 240mg/kg/infusion. Tumor cells derived from TriN 2755 IV bolus treated rats had an impaired colony formation compared to non-treated tumors in vitro.

Moreover, an enhancement of the antitumor activity of drugs alone was observed in the SC MDA MB-231 tumor bearing nude rats model when TriN 2755 at 240 mg/kg/infusion was combined with CPT-11 at 40 mg/kg/inj or Docetaxel at 2.5 mg/kg/inj.

Conclusions: These results demonstrate that TriN 2755 dosed by IV infusion and IV bolus displayed a marked antitumor activity alone, and efficacy of IV infusion was increased by combination with CPT-11 or Docetaxel in SC nude rats human breast tumor model. TriN 2755 is currently under evaluation in phase I clinical trials for the treatment of solid tumors.

Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2525. doi:10.1158/1538-7445.AM2011-2525

Experimental evidence of space charge driven emittance coupling in high intensity linear accelerators

In high intensity linacs emittance exchange driven by space charge coupling may lead to the well-known "equipartitioning" phenomenon if the stop band at sigma(parallel) = sigma(perpendicular) is crossed at sufficiently slow rate. This Letter is the first experimental evidence of this phenomenon in a high intensity linear accelerator, here the UNILAC at GSI. Measurements of emittances at the entrance and exit of one drift tube linac tank comprising 15 lattice cells are taken for a set of transverse and longitudinal tunes. The onset of exchange on the stop band of previously derived "stability charts" confirms theoretical predictions. The measured transverse emittance growth also compares well with results from the beam dynamics simulation codes DYNAMION and TRACEWIN.

Experimental evidence of the 90 degrees stop band in the GSI UNILAC

In a particle accelerator with a periodic structure beam space charge force may excite resonant beam emittance growth if the particle's transverse phase advance approaches 90 degrees . A recent simulation study with the PARMILA code [D. Jeon, Phys. Rev. ST Accel. Beams 12, 054204 (2009)]10.1103/PhysRevSTAB.12.054204 has shown the feasibility of measuring the stop band of this fourth order resonance in the GSI Universal Linear Accelerator UNILAC and proposed its experimental verification, which is reported here. Measurements of transverse phase space distributions behind a periodically focusing structure reveal a fourfold symmetry characteristic of fourth order resonances as well as a resonance stop band above sigma_{0}=90 degrees per focusing cell. These experimental findings agree with results from three different beam dynamics simulation codes, i.e., DYNAMION, PARMILA, and TRACEWIN.

Risk factors in the population of the GDR-MONICA Study (1983/84)

The GDR-MONICA project comprises 25 administratively defined areas with a population of nearly two million people aged 25-64. Data from the first random sample survey are reported here. The survey gathered information regarding risk factors, dietary behaviour, physical activity and psychosocial factors from 11,281 persons aged 25-64. The average risk factor levels were high in the population: The mean casual blood pressure was 140/88 mmHg and 138/86 mmHg for men and women respectively. In both sexes the mean total cholesterol level exceeded 6.1 mmol/L, and the mean body mass index (BMI) was just over 26.0. The study population consumed, on average, excessive amounts of energy, fat, alcohol, and sodium, and too few carbohydrates. Preliminary conclusions regarding unfavourable trends in risk factor levels have been drawn by comparing the present data with other recent reliable epidemiological studies.

Human alveolar long-term clearance of ferromagnetic iron oxide microparticles in healthy and diseased subjects

Monodisperse ferrimagnetic microparticles (Fe3O4) with 1.3 microm geometric diameter were inhaled to study alveolar long-term clearance in healthy and diseased human subjects. Nineteen younger (age 20 to 39 years) and 20 older (age 40 to 65 years) healthy volunteers participated in the study as well as 15 patients with sarcoidosis (SAR), 12 patients with idiopathic pulmonary fibrosis (IPF), and 15 patients with chronic obstructive bronchitis (COB). In each group the subjects were divided into never smokers (NS) and active smokers (S). Clearance was measured by magnetopneumography (MPG) for 300 days after inhalation. In COB, 50% of the deposited particles were removed from the lungs after 2 days, indicating high bronchial deposits due to bronchial obstructions. In healthy NS, only 10% of the particles were removed after 2 days and cigarette smoking enhanced the fraction of fast-cleared particles. In subjects who smoked, slow clearance was significantly impaired (P < . 02). Clearance half-lives (in days) for younger, healthy, NS were 124 +/- 66 (mean +/- SD) compared to 220 +/- 74 for S. Similarly for older subjects, the timeswere 162 +/- 120 for NS and 459 +/- 334 for S. The impairment of alveolar clearance due to cigarette smoking increases by 5.7 +/- 1.3 days/pack-year (P < .01). Alveolar clearance was impaired in SAR and in IPF; half-lives were 275 +/- 109 days (P < .05) and 756 +/- 345 days (P < .02), respectively, compared to healthy NS. Most COB patients were ex-smokers, their long-term clearance was 240 +/- 74 days, which is more than healthy NS (P < .01), but less than healthy S and might indicate a recovery of alveolar clearance. In view of studies using totally inert particles like Teflon, we conclude that the lung clearance measured with iron oxide tracer particles primarily reflects clearance by intraphagosomal particle dissolution within alveolar macrophages, which is impaired by cigarette smoke consumption and in patients.

Transient pleural effusion in norepinephrine-stimulated rats

Transient pleural effusions occurred in rats receiving continuous intravenous infusion of norepinephrine (NE, 0.1 mg/kg/h). We hypothesized that these pleural effusions result from a NE-induced increase in right ventricular systolic pressure (RVSP) and total peripheral resistance (TPR). NE was administered over time intervals between 20 min and 72 h. It induced an immediate doubling in RVSP whereas LVSP remained at the control level. TPR increased with a delay of 6 h. At this time, pleural effusions occurred in NE-treated animals, reached their maximum after 8h and disappeared after 24 h of NE stimulation. Combining NE with the alpha-blocker prazosin normalized TPR and prevented pleural effusions. Therefore, we interpret the pleural effusion as a consequence of pulmonary venous congestion, mainly caused by an increased TPR. LV hypertrophy which developed after 24 h of NE stimulation is considered to compensate for the hemodynamic disturbance due to the NE-induced elevation in TPR. This is reflected in the disappearance of pleural effusion.

Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab

A 55 year old man with chronic lymphocytic leukaemia (CLL) and rheumatoid arthritis (RA), treated for four years with methotrexate (MTX), who developed a B cell non-Hodgkin's lymphoma (B-NHL), is described. The tumour was localised to the shoulder and axillary lymph nodes, and positive for Epstein-Barr viral antigens. After failure of radiation and chemotherapy, a complete remission was achieved with a combination of antibody treatment (rituximab) and EPOCH. The development of a second malignancy in a patient with RA receiving MTX has not been described before. The summation of T cell deficiencies induced by MTX, CLL, and RA may all have contributed to the development of the B-NHL.

Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats

Extensive myocardial remodeling occurs after transmural myocardial infarction (MI). The infarcted myocardium is being replaced by scar tissue after gradual resorption of the necrotic tissue. The remodeling process involves both synthesis and degradation of collagens as major components of the extracellular matrix (ECM). In the present study we have analyzed the time-dependent changes of the processes related to this fibrosis in the infarct area and in the non-infarcted left ventricle (LV) six hours to 82 days after occlusion of the left anterior descending coronary artery (LAD) in rats. We also examined whether changes occurred in the expression pattern of the transforming growth factor (TGF) beta isoforms, since this cytokine is known as powerful inductor of fibrosis. Elevation in colligin expression preceded the pronounced increase in mRNA expression of both type I and type III collagen after MI from day three onwards. The maximal increase in colligin protein in the infarct area coincided with the most pronounced expression of collagen I and collagen III mRNA expression. Also, the expression and activity of matrix metalloproteinases (MMPs) and of tissue inhibitor of matrix metalloproteinase (TIMP)-2 mRNA were increased predominantly in the infarct area. TGF beta(1)and TGF-beta(2)expression increased within the first days after MI, whereas TGF-beta(3)expression was elevated predominantly in the infarct area. This pronounced increase in TGF-beta(3)persisted up to 82 days and correlated positively with the parameters of ECM metabolism. Thus, the scar formation is an ongoing dynamic process in which TGF-beta(3)seems to play an active role in the complex ventricular remodeling.

Pregnancy and labor increase the capacity of human myometrial cells to secrete parathyroid hormone-related protein

Parathyroid hormone-related protein (PTHrP), a oncofetal gene product possessing smooth muscle relaxant properties, has been found in rat and human uterine smooth muscle cells (USMC) where it is postulated to regulate myometrial tone and/or blood flow. Studies investigating the gestational regulation of PTHrP in human USMC have not been performed. This study was conducted to determine if pregnancy alters the capacity of USMC to secrete or respond to PTHrP. USMC cultures were established from 8 hysterectomy specimens (H) and 7 non-laboring (NP) and 5 laboring term pregnant uterine biopsies (LP). PTHrP secretion was measured at baseline and in response to TGF-beta1 using a immunoradiometric assay. The USMC response to PTHrP was assessed by incubating cultures with human (1-34)PTHrP and measuring cellular cAMP by radioimmunoassay. We found that cultures from the groups did not differ with respect to basal PTHrP secretion. TGF-beta1, on the other hand, produced dose-dependent increases in secreted PTHrP in each group such that LP>NP>H at 12 hrs and LP>NP and H 24 hrs. Maximal responses were found at 24 hrs in cells treated with 10 ng/ml TGF-beta1 (LP: 2034+/-366 vs NP: 1485+/-427; H: 1250+/-202 fmol/mg). Incubation of cultures with PTHrP produced dose-dependent increases in cAMP production, with 10(-7) M increasing levels by 64%. Neither pregnancy nor labor significantly affected the cAMP response. These findings indicate that the human myometrium has the capacity to increase PTHrP secretion during pregnancy and labor through a TGF-beta-dependent pathway. Such findings are consistent with a role of PTHrP in enhancing uterine blood flow.

Electrical multisite stimulation of the isolated chicken retina

Visual prostheses such as subretinal implants are intended for electrical multisite excitation of the retinal network. To investigate relevant issues like spatial resolution and operational range, we have developed an in vitro method using microelectrode arrays to stimulate isolated retinae. Ganglion cell activity in the chicken retina evoked by distally applied spatial voltage patterns consisted of fast bursts, transient inhibition and delayed discharges, and depended on the amount, location and spatial pattern of the injected charge. The response was altered or disappeared when synaptic transmission was blocked. Our results indicate that shape perception and object location can be partially achieved with subretinal electrical multisite stimulation.

Changes in the mRNA expression of cytokines and chemokines by stimulated RPE cells in vitro

PURPOSE

The transplantation of retinal pigment epithelial (RPE) cells is a possible therapy for degenerative diseases of the retina. However, the immune response and the subsequent rejection of the allografts are major problems in this field. We investigated the effect of pro-inflammatory factors on the cytokine and chemokine mRNA expression of human RPE cells during long-term observations in vitro.

METHODS

Human RPE cells were cultured in the presence of tumor necrosis factor-alpha (TNF-alpha, 10 ng/ml), interferon-gamma (IFN-gamma, 1000 U/ml) or with a combination of both up to 96 hours. Cells were harvested and total RNA was isolated. The changes in expression of mRNA coding for RANTES, the interleukines (IL)-6, 8, 10, 15, IFN-gamma, monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta1 (TGF-beta1) during the stimulation were investigated using the ribonuclease protection assay.

RESULTS

IL-10 and IFN-gamma mRNA were detected in neither unstimulated nor stimulated cells. Human RPE cells constitutively express the mRNA for IL-6, MCP-1, IL-8, IL-15, TGF-beta1 and, at very low levels, for RANTES. The TGF-beta1 mRNA expression was not influenced by either stimulation. The mRNA of the other factors was up-regulated for 24-48 h dependent on the stimulation.

CONCLUSIONS

Human RPE cells are able to increase their mRNA expression for the detected cytokines in response to the pro-inflammatory factors which are detectable in the rejection process. These up-regulated cytokines themselves are known to be involved in several inflammatory and immunological processes, suggesting their role in the rejection of transplanted RPE allografts.